단장증후군 시장 - 세계 시장 규모, 점유율, 동향 분석, 기회, 예측 보고서(2019-2029년)

Short Bowel Syndrome Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Type ; By Distribution Channel ; By Region

US $ 4,850 ￦ 6,848,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,750 ￦ 8,119,000

Unprintable PDF (Group License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150 ￦ 11,507,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. Excel 파일이 제공됩니다.

한글목차

단장증후군 세계 시장 규모는 2029년까지 20억 달러를 넘어설 것으로 전망

세계 단장증후군(SBS) 시장은 비경구 영양의 높은 비용과 단장증후군 유병률 증가로 인한 SBS 치료제 수요 증가로 호황을 누리고 있습니다.

전략 컨설팅 및 시장 조사 전문 기업 BlueWeave Consulting은 최근 조사에서 2022년 단장증후군 세계 시장 규모를 8억 2,829만 달러로 추산했습니다. 2023년부터 2029년까지 예측 기간 동안 BlueWeave, 세계 단장증후군 시장 규모는 14.05%의 높은 CAGR로 확대되어 2029년에는 20억 5,324만 달러에 달할 것으로 예측하고 있습니다. 세계 단장증후군 시장의 주요 성장 촉진요인으로는 소화기 질환의 유병률 증가, 의료 기술의 발전, 의료진과 환자의 인식 증가 등을 들 수 있습니다. 단장증후군의 발생률은 전 세계적으로 증가하고 있으며, 주요 원인은 소화관 수술, 선천성 기형, 염증성 장 질환 및 소장의 대부분을 절제하거나 기능 장애를 유발하는 기타 질환과 같은 요인으로 인해 증가하고 있습니다. 이러한 유병률의 증가는 효과적인 치료 옵션에 대한 수요를 창출하고 있습니다. 의료 기술의 발전은 단장증후군에 대한 혁신적인 치료법 개발에 중요한 역할을 하고 있습니다. 이러한 발전에는 비경구 영양 솔루션, 장 이식술, 장 재활 프로그램 등이 포함되며, 이는 환자의 결과를 개선하고 시장 성장에 기여하고 있습니다. 또한, 제약회사와 연구기관들은 단장증후군에 대한 새로운 치료법을 발견하고 개발하기 위해 연구개발에 적극적으로 투자하고 있습니다. 이러한 노력은 환자의 삶의 질을 개선하고 이 분야의 미충족 의료 수요를 충족시키기 위한 것입니다. 결과적으로 이러한 요인들은 예측 기간 동안 세계 단장증후군 시장의 성장을 촉진할 것으로 예상됩니다. 그러나 SBS 치료의 높은 비용과 SBS의 장기적인 합병증은 분석 기간 동안 전체 시장 성장을 억제할 것으로 예상됩니다.

이 보고서는 세계 단장증후군 시장의 성장 잠재력, 향후 동향 및 통계에 대한 정보를 제공하기 위해 상세한 분석을 제공합니다. 또한 전체 시장 규모 예측을 촉진하는 요인도 다루고 있습니다. 이 보고서는 세계 단장증후군 시장의 최근 기술 동향과 의사결정자가 건전한 전략적 의사결정을 내릴 수 있는 업계 인사이트를 제공하기 위해 최선을 다하고 있습니다. 또한, 시장 성장 촉진요인, 과제, 경쟁력에 대해서도 분석합니다.

목차

제1장 조사 체계

제2장 주요 요약

제3장 세계의 단장증후군 시장에 관한 인사이트

• 업계의 밸류체인 분석
• DROC 분석
  • 성장 촉진요인
    • 단장증후군 유병률 증가
    • 비경구 영양비 급등에 의해 SBS 의약품 수요가 증대
  • 성장 억제요인
    • 고액의 SBS 치료비
    • SBS 장기 합병증
  • 기회
    • 새로운 SBS약과 치료법의 개발
    • 타사와의 파트너십 및 협업
  • 과제
    • 엄격한 규제 요건
    • 제네릭 의약품과의 경쟁
• 기술 진보/최근의 개발
• 규제 체계
• Porter's Five Forces 분석

제4장 세계의 단장증후군 시장 개요

• 시장 규모와 예측, 2019-2029년
  • 금액별
• 시장 점유율과 예측
  • 유형별
    • GLP-2
    • 성장 호르몬
    • 글루타민
    • 기타
  • 유통 채널별
    • 병원 약국
    • 소매 약국
    • 기타
  • 지역별
    • 북미
    • 유럽
    • 아시아태평양(APAC)
    • 라틴아메리카(LATAM)
    • 중동 및 아프리카(MEA)

제5장 북미 단장증후군 시장

• 시장 규모와 예측, 2019-2029년
  • 금액별
• 시장 점유율과 예측
  • 유형별
  • 유통 채널별
  • 국가별
    • 미국
    • 캐나다

제6장 유럽 단장증후군 시장

• 시장 규모와 예측, 2019-2029년
  • 금액별
• 시장 점유율과 예측
  • 유형별
  • 유통 채널별
  • 국가별
    • 독일
    • 영국
    • 이탈리아
    • 프랑스
    • 스페인
    • 벨기에
    • 러시아
    • 기타 유럽

제7장 아시아태평양의 단장증후군 시장

• 시장 규모와 예측, 2019-2029년
  • 금액별
• 시장 점유율과 예측
  • 유형별
  • 유통 채널별
  • 국가별
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주와 뉴질랜드
    • 인도네시아
    • 말레이시아
    • 싱가포르
    • 베트남
    • APAC의 기타 지역

제8장 라틴아메리카 단장증후군 시장

• 시장 규모와 예측, 2019-2029년
  • 금액별
• 시장 점유율과 예측
  • 유형별
  • 유통 채널별
  • 국가별
    • 브라질
    • 멕시코
    • 아르헨티나
    • 페루
    • 중남미의 기타 지역

제9장 중동 및 아프리카의 단장증후군 시장

• 시장 규모와 예측, 2019-2029년
  • 금액별
• 시장 점유율과 예측
  • 유형별
  • 유통 채널별
  • 국가별
    • 사우디아라비아
    • 아랍에미리트
    • 카타르
    • 쿠웨이트
    • 남아프리카공화국
    • 나이지리아
    • 알제리
    • MEA의 기타 지역

제10장 경쟁 상황

• 주요 기업과 그 제품 리스트
• 세계의 단장증후군 시장 점유율 분석, 2022년
• 동작 파라미터에 의한 경쟁 벤치마킹
• 주요 전략적 전개(합병, 인수, 파트너십 등)

제11장 세계의 단장증후군 시장에 대한 COVID-19의 영향

제12장 기업 개요(기업 개요, 재무 매트릭스, 경쟁 상황, 주요 인재, 주요 경쟁, 연락처 주소, 전략적 전망, SWOT 분석)

• Takeda
• Emmaus Life Sciences
• Nutricia(Danone)
• Merck KGaA
• GlyPharma Therapeutics
• Zealand Pharma
• Sancilio Pharmaceuticals
• Naia Pharmaceuticals
• Ardelyx
• Adocia
• Aralez Pharmaceuticals
• Shield Therapeutics
• OxThera
• Rhythm Pharmaceuticals
• Pivot Pharmaceuticals
• Other Prominent Players

제13장 주요 전략적 추천사항

제14장 조사 방법

• 정성적 조사
  • 1차 및 2차 조사
• 정량적 조사
• 시장 내역과 데이터 삼각측량
  • 2차 조사
  • 1차 조사
• 1차 조사 응답자의 지역별 내역
• 가정과 제한

※ 비상장 기업의 재무 정보도 수시 제공 가능합니다.

ksm

영문 목차

영문목차

Global Short Bowel Syndrome Market Size Booming to Cross USD 2 Billion by 2029.

Global short bowel syndrome (SBS) market is flourishing because of an increasing demand for SBS drugs due to the high cost of parenteral nutrition and the growing prevalence of short bowel syndrome.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the global short bowel syndrome market size at USD 828.29 million in 2022. During the forecast period between 2023 and 2029, BlueWeave expects the global short bowel syndrome market size to expand at a significant CAGR of 14.05% reaching a value of USD 2,053.24 million by 2029. Major growth drivers for the global short bowel syndrome market include an increasing prevalence of gastrointestinal disorders, advancements in medical technology, and growing awareness among healthcare professionals and patients. The incidence of short bowel syndrome is rising globally, primarily due to factors such as gastrointestinal surgeries, congenital anomalies, inflammatory bowel diseases, and other conditions leading to the removal or dysfunction of a significant portion of the small intestine. This growing prevalence has created a demand for effective treatment options. Advancements in medical technology have played a crucial role in the development of innovative therapies for short bowel syndrome. These advancements encompass parenteral nutrition solutions, intestinal transplantation procedures, and intestinal rehabilitation programs, which have improved patient outcomes and are contributing to market growth. Also, pharmaceutical companies and research organizations are actively investing in research and development efforts to discover and develop new treatment options for short bowel syndrome. These initiatives aim to enhance patients' quality of life and address the existing unmet medical needs in this field. As a result, these factors are expected to drive the expansion of the global short bowel syndrome market throughout the forecast period. However, the high cost of SBS treatment and long-term complications of SBS are anticipated to restrain the overall market growth during the period in analysis.

Global Short Bowel Syndrome Market - Overview:

The global Short Bowel Syndrome (SBS) market encompasses the diagnosis, treatment, and management of a condition characterized by the loss or dysfunction of a significant portion of the small intestine. It involves pharmaceutical companies, medical device manufacturers, research organizations, and healthcare providers. Key products and services include pharmacological therapies, parenteral nutrition solutions, medical devices, surgical interventions, rehabilitation programs, and support services. The market is driven by factors such as the rising prevalence of gastrointestinal disorders, advancements in medical technology, research and development investments, and the need for effective SBS management. Market players strive to develop innovative therapies and interventions to improve patient outcomes and quality of life.

Impact of COVID-19 on Global Short Bowel Syndrome Market:

COVID-19 pandemic adversely affected the global short bowel syndrome market. The healthcare systems' focus on managing COVID-19 cases, disruptions in the supply chain, and restrictions on non-essential healthcare services have affected the diagnosis, treatment, and management of SBS. Clinical trials for new therapies and medical device development have been delayed or halted, impacting research and development activities. Also, the economic impact of the pandemic has affected healthcare budgets, potentially limiting patients' access to expensive SBS treatments. However, as the situation improved, the market gradually recovered, supported by increased healthcare investments and a resurgence in research and development efforts.

Global Short Bowel Syndrome Market - By Type:

By type, the global short bowel syndrome market is divided into GLP-2, Growth Hormone, and Glutamine segments. The GLP-2 (glucagon-like peptide-2) segment holds the highest share in the global Short Bowel Syndrome (SBS) market due to its effectiveness in managing the condition. GLP-2 is a hormone that plays a crucial role in promoting intestinal growth, enhancing nutrient absorption, and reducing fluid loss. It has shown promising results in clinical trials and is approved for the treatment of SBS in several regions. GLP-2 therapies, such as Teduglutide, have demonstrated the ability to reduce dependence on parenteral nutrition and improve intestinal function. The proven efficacy of GLP-2 treatments has led to their widespread adoption, contributing to the segment's dominant market share in the global SBS market.

Competitive Landscape:

Major players operating in the global short bowel syndrome market include: Takeda, Emmaus Life Sciences, Nutricia (Danone), Merck KGaA, GlyPharma Therapeutics, Zealand Pharma, Sancilio Pharmaceuticals, Naia Pharmaceuticals, Ardelyx, Adocia, Aralez Pharmaceuticals, Shield Therapeutics, OxThera, Rhythm Pharmaceuticals, and Pivot Pharmaceuticals. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Short Bowel Syndrome Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Short Bowel Syndrome Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

• 1.1. Research Objective
• 1.2. Product Overview
• 1.3. Market Segmentation

2. Executive Summary

3. Global Short Bowel Syndrome Market Insights

• 3.1. Industry Value Chain Analysis
• 3.2. DROC Analysis
  • 3.2.1. Growth Drivers
    • 3.2.1.1. Increasing prevalence of short bowel syndrome
    • 3.2.1.2. Growing demand for SBS drugs due to the high cost of parenteral nutrition
  • 3.2.2. Restraints
    • 3.2.2.1. High cost of SBS treatment
    • 3.2.2.2. Long-term complications of SBS
  • 3.2.3. Opportunities
    • 3.2.3.1. Development of new SBS drugs and therapies
    • 3.2.3.2. Partnerships and collaborations with other companies
  • 3.2.4. Challenges
    • 3.2.4.1. Stringent regulatory requirements
    • 3.2.4.2. Competition from generic drugs
• 3.3. Technology Advancements/Recent Developments
• 3.4. Regulatory Framework
• 3.5. Porter's Five Forces Analysis
  • 3.5.1. Bargaining Power of Suppliers
  • 3.5.2. Bargaining Power of Buyers
  • 3.5.3. Threat of New Entrants
  • 3.5.4. Threat of Substitutes
  • 3.5.5. Intensity of Rivalry

4. Global Short Bowel Syndrome Market Overview

• 4.1. Market Size & Forecast, 2019-2029
  • 4.1.1. By Value (USD Million)
• 4.2. Market Share and Forecast
  • 4.2.1. By Type
    • 4.2.1.1. GLP-2
    • 4.2.1.2. Growth Hormone
    • 4.2.1.3. Glutamine
    • 4.2.1.4. Others
  • 4.2.2. By Distribution Channel
    • 4.2.2.1. Hospital Pharmacies
    • 4.2.2.2. Retail Pharmacies
    • 4.2.2.3. Others
  • 4.2.3. By Region
    • 4.2.3.1. North America
    • 4.2.3.2. Europe
    • 4.2.3.3. Asia Pacific (APAC)
    • 4.2.3.4. Latin America (LATAM)
    • 4.2.3.5. Middle East and Africa (MEA)

5. North America Short Bowel Syndrome Market

• 5.1. Market Size & Forecast, 2019-2029
  • 5.1.1. By Value (USD Million)
• 5.2. Market Share & Forecast
  • 5.2.1. By Type
  • 5.2.2. By Distribution Channel
  • 5.2.3. By Country
    • 5.2.3.1. United States
    • 5.2.3.1.1. By Type
    • 5.2.3.1.2. By Distribution Channel
    • 5.2.3.2. Canada
    • 5.2.3.2.1. By Type
    • 5.2.3.2.2. By Distribution Channel

6. Europe Short Bowel Syndrome Market

• 6.1. Market Size & Forecast, 2019-2029
  • 6.1.1. By Value (USD Million)
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Distribution Channel
  • 6.2.3. By Country
    • 6.2.3.1. Germany
    • 6.2.3.1.1. By Type
    • 6.2.3.1.2. By Distribution Channel
    • 6.2.3.2. United Kingdom
    • 6.2.3.2.1. By Type
    • 6.2.3.2.2. By Distribution Channel
    • 6.2.3.3. Italy
    • 6.2.3.3.1. By Type
    • 6.2.3.3.2. By Distribution Channel
    • 6.2.3.4. France
    • 6.2.3.4.1. By Type
    • 6.2.3.4.2. By Distribution Channel
    • 6.2.3.5. Spain
    • 6.2.3.5.1. By Type
    • 6.2.3.5.2. By Distribution Channel
    • 6.2.3.6. Belgium
    • 6.2.3.6.1. By Type
    • 6.2.3.6.2. By Distribution Channel
    • 6.2.3.7. Russia
    • 6.2.3.7.1. By Type
    • 6.2.3.7.2. By Distribution Channel
    • 6.2.3.8. Rest of Europe
    • 6.2.3.8.1. By Type
    • 6.2.3.8.2. By Distribution Channel

7. Asia Pacific Short Bowel Syndrome Market

• 7.1. Market Size & Forecast, 2019-2029
  • 7.1.1. By Value (USD Million)
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Distribution Channel
  • 7.2.3. By Country
    • 7.2.3.1. China
    • 7.2.3.1.1. By Type
    • 7.2.3.1.2. By Distribution Channel
    • 7.2.3.2. India
    • 7.2.3.2.1. By Type
    • 7.2.3.2.2. By Distribution Channel
    • 7.2.3.3. Japan
    • 7.2.3.3.1. By Type
    • 7.2.3.3.2. By Distribution Channel
    • 7.2.3.4. South Korea
    • 7.2.3.4.1. By Type
    • 7.2.3.4.2. By Distribution Channel
    • 7.2.3.5. Australia & New Zealand
    • 7.2.3.5.1. By Type
    • 7.2.3.5.2. By Distribution Channel
    • 7.2.3.6. Indonesia
    • 7.2.3.6.1. By Type
    • 7.2.3.6.2. By Distribution Channel
    • 7.2.3.7. Malaysia
    • 7.2.3.7.1. By Type
    • 7.2.3.7.2. By Distribution Channel
    • 7.2.3.8. Singapore
    • 7.2.3.8.1. By Type
    • 7.2.3.8.2. By Distribution Channel
    • 7.2.3.9. Vietnam
    • 7.2.3.9.1. By Type
    • 7.2.3.9.2. By Distribution Channel
    • 7.2.3.10. Rest of APAC
    • 7.2.3.10.1. By Type
    • 7.2.3.10.2. By Distribution Channel

8. Latin America Short Bowel Syndrome Market

• 8.1. Market Size & Forecast, 2019-2029
  • 8.1.1. By Value (USD Million)
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Distribution Channel
  • 8.2.3. By Country
    • 8.2.3.1. Brazil
    • 8.2.3.1.1. By Type
    • 8.2.3.1.2. By Distribution Channel
    • 8.2.3.2. Mexico
    • 8.2.3.2.1. By Type
    • 8.2.3.2.2. By Distribution Channel
    • 8.2.3.3. Argentina
    • 8.2.3.3.1. By Type
    • 8.2.3.3.2. By Distribution Channel
    • 8.2.3.4. Peru
    • 8.2.3.4.1. By Type
    • 8.2.3.4.2. By Distribution Channel
    • 8.2.3.5. Rest of LATAM
    • 8.2.3.5.1. By Type
    • 8.2.3.5.2. By Distribution Channel

9. Middle East & Africa Short Bowel Syndrome Market

• 9.1. Market Size & Forecast, 2019-2029
  • 9.1.1. By Value (USD Million)
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Distribution Channel
  • 9.2.3. By Country
    • 9.2.3.1. Saudi Arabia
    • 9.2.3.1.1. By Type
    • 9.2.3.1.2. By Distribution Channel
    • 9.2.3.2. UAE
    • 9.2.3.2.1. By Type
    • 9.2.3.2.2. By Distribution Channel
    • 9.2.3.3. Qatar
    • 9.2.3.3.1. By Type
    • 9.2.3.3.2. By Distribution Channel
    • 9.2.3.4. Kuwait
    • 9.2.3.4.1. By Type
    • 9.2.3.4.2. By Distribution Channel
    • 9.2.3.5. South Africa
    • 9.2.3.5.1. By Type
    • 9.2.3.5.2. By Distribution Channel
    • 9.2.3.6. Nigeria
    • 9.2.3.6.1. By Type
    • 9.2.3.6.2. By Distribution Channel
    • 9.2.3.7. Algeria
    • 9.2.3.7.1. By Type
    • 9.2.3.7.2. By Distribution Channel
    • 9.2.3.8. Rest of MEA
    • 9.2.3.8.1. By Type
    • 9.2.3.8.2. By Distribution Channel

10. Competitive Landscape

• 10.1. List of Key Players and Their Offerings
• 10.2. Global Short Bowel Syndrome Market Share Analysis, 2022
• 10.3. Competitive Benchmarking, By Operating Parameters
• 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Short Bowel Syndrome Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

• 12.1. Takeda
• 12.2. Emmaus Life Sciences
• 12.3. Nutricia (Danone)
• 12.4. Merck KGaA
• 12.5. GlyPharma Therapeutics
• 12.6. Zealand Pharma
• 12.7. Sancilio Pharmaceuticals
• 12.8. Naia Pharmaceuticals
• 12.9. Ardelyx
• 12.10. Adocia
• 12.11. Aralez Pharmaceuticals
• 12.12. Shield Therapeutics
• 12.13. OxThera
• 12.14. Rhythm Pharmaceuticals
• 12.15. Pivot Pharmaceuticals
• 12.16. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

• 14.1. Qualitative Research
  • 14.1.1. Primary & Secondary Research
• 14.2. Quantitative Research
• 14.3. Market Breakdown & Data Triangulation
  • 14.3.1. Secondary Research
  • 14.3.2. Primary Research
• 14.4. Breakdown of Primary Research Respondents, By Region
• 14.5. Assumptions & Limitations

*Financial information of case of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

Figures

• Figure 1 Global Short Bowel Syndrome Market Segmentation
• Figure 2 Global Short Bowel Syndrome Market Value Chain Analysis
• Figure 3 Company Market Share Analysis, 2022
• Figure 4 Global Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 5 Global Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 6 Global Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 7 Global Short Bowel Syndrome Market Share, By Region, By Value, 2019-2029
• Figure 8 North America Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 9 North America Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 10 North America Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 11 North America Short Bowel Syndrome Market Share, By Country, By Value, 2019-2029
• Figure 12 United States Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 13 United States Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 14 United States Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 15 Canada Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 16 Canada Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 17 Canada Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 18 Europe Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 19 Europe Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 20 Europe Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 21 Europe Short Bowel Syndrome Market Share, By Country, By Value, 2019-2029
• Figure 22 Germany Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 23 Germany Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 24 Germany Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 25 United Kingdom Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 26 United Kingdom Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 27 United Kingdom Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 28 Italy Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 29 Italy Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 30 Italy Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 31 France Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 32 France Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 33 France Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 34 Spain Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 35 Spain Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 36 Spain Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 37 Belgium Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 38 Belgium Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 39 Belgium Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 40 Rest of Europe Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 41 Rest of Europe Short Bowel Syndrome Market Share, By Technology, By Value, 2019-2029
• Figure 42 Rest of Europe Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 43 The Asia-Pacific Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 44 The Asia-Pacific Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 45 The Asia-Pacific Short Bowel Syndrome Market Share, By Deployment, By Value, 2019-2029
• Figure 46 The Asia-Pacific Short Bowel Syndrome Market Share, By Country, By Value, 2019-2029
• Figure 47 China Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 48 China Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 49 China Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 50 India Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 51 India Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 52 India Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 53 Japan Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 54 Japan Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 55 Japan Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 56 South Korea Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 57 South Korea Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 58 South Korea Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 59 Australia & New Zealand Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 60 Australia & New Zealand Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 61 Australia & New Zealand Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 62 Indonesia Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 63 Indonesia Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 64 Indonesia Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 65 Malaysia Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 66 Malaysia Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 67 Malaysia Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 68 Singapore Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 69 Singapore Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 70 Singapore Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 71 Vietnam Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 72 Vietnam Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 73 Vietnam Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 74 Rest of Asia Pacific Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 75 Rest of Asia Pacific Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 76 Rest of Asia Pacific Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 77 Latin America Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 78 Latin America Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 79 Latin America Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 80 Latin America Short Bowel Syndrome Market Share, By Country, By Value, 2019-2029
• Figure 81 Brazil Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 82 Brazil Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 83 Brazil Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 84 Mexico Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 85 Mexico Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 86 Mexico Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 87 Argentina Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 88 Argentina Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 89 Argentina Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 90 Peru Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 91 Peru Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 92 Peru Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 93 Rest of Latin America Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 94 Rest of Latin America Short Bowel Syndrome Market Share, By Type By Value, 2019-2029
• Figure 95 Rest of Latin America Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 96 The Middle East & Africa Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 97 The Middle East & Africa Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 98 The Middle East & Africa Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 99 The Middle East & Africa Short Bowel Syndrome Market Share, By Country, By Value, 2019-2029
• Figure 100 Saudi Arabia Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 101 Saudi Arabia Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 102 Saudi Arabia Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 103 UAE Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 104 UAE Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 105 UAE Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 106 Qatar Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 107 Qatar Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 108 Qatar Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 109 Kuwait Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 110 Kuwait Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 111 Kuwait Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 112 Iran Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 113 Iran Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 114 Iran Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 115 South Africa Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 116 South Africa Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 117 South Africa Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 118 Nigeria Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 119 Nigeria Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 120 Nigeria Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 121 Kenya Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 122 Kenya Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 123 Kenya Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 124 Egypt Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 125 Egypt Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 126 Egypt Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 127 Morocco Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 128 Morocco Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 129 Morocco Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 130 Algeria Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 131 Algeria Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 132 Algeria Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
• Figure 133 Rest of Middle East & Africa Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
• Figure 134 Rest of Middle East & Africa Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
• Figure 135 Rest of Middle East & Africa Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029

Tables

• Table 1 Global Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 2 Global Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 3 Global Short Bowel Syndrome Market Size, By Region, By Value, 2019-2029
• Table 4 North America Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 5 North America Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 6 North America Short Bowel Syndrome Market Size, By Country, By Value, 2019-2029
• Table 7 United States Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 8 United States Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 9 Canada Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 10 Canada Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 11 Europe Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 12 Europe Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 13 Europe Short Bowel Syndrome Market Size, By Country, By Value, 2019-2029
• Table 14 Germany Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 15 Germany Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 16 United Kingdom Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 17 United Kingdom Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 18 Italy Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 19 Italy Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 20 France Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 21 France Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 22 Spain Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 23 Spain Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 24 Belgium Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 25 Belgium Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 26 Rest of Europe Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 27 Rest of Europe Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 28 The Asia-Pacific Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 29 The Asia-Pacific Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 30 The Asia-Pacific Short Bowel Syndrome Market Size, By Country, By Value, 2019-2029
• Table 31 China Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 32 China Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 33 India Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 34 India Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 35 Japan Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 36 Japan Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 37 South Korea Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 38 South Korea Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 39 Australia & New Zealand Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 40 Australia & New Zealand Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 41 Indonesia Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 42 Indonesia Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 43 Malaysia Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 44 Malaysia Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 45 Singapore Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 46 Singapore Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 47 Philippines Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 48 Philippines Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 49 Vietnam Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 50 Vietnam Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 51 Rest of Asia Pacific Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 52 Rest of Asia Pacific Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 53 Latin America Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 54 Latin America Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 55 Latin America Short Bowel Syndrome Market Size, By Country, By Value, 2019-2029
• Table 56 Brazil Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 57 Brazil Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 58 Mexico Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 59 Mexico Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 60 Argentina Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 61 Argentina Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 62 Peru Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 63 Peru Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 64 Rest of Latin America Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 65 Rest of Latin America Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 66 The Middle East & Africa Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 67 The Middle East & Africa Short Bowel Syndrome Market Size, By Country, By Value, 2019-2029
• Table 68 Saudi Arabia Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 69 Saudi Arabia Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 70 UAE Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 71 UAE Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 72 Qatar Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 73 Qatar Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 74 Kuwait Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 75 Kuwait Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 76 Iran Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 77 Iran Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 78 South Africa Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 79 South Africa Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 80 Nigeria Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 81 Nigeria Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 82 Kenya Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 83 Kenya Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 84 Egypt Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 85 Egypt Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 86 Morocco Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 87 Morocco Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 88 Algeria Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 89 Algeria Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 90 Rest of Middle East & Africa Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
• Table 91 Rest of Middle East & Africa Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
• Table 92 Takeda Company Overview
• Table 93 Takeda Financial Overview
• Table 94 Emmaus Life Sciences Company Overview
• Table 95 Emmaus Life Sciences Financial Overview
• Table 96 Nutricia (Danone) Company Overview
• Table 97 Nutricia (Danone) Financial Overview
• Table 98 Merck KGaA Company Overview
• Table 99 Merck KGaA Financial Overview
• Table 100 GlyPharma Therapeutics Company Overview
• Table 101 GlyPharma Therapeutics Financial Overview
• Table 102 Zealand Pharma Company Overview
• Table 103 Zealand Pharma Financial Overview
• Table 104 Sancilio Pharmaceuticals Company Overview
• Table 105 Sancilio Pharmaceuticals Financial Overview
• Table 106 Naia Pharmaceuticals Company Overview
• Table 107 Naia Pharmaceuticals Financial Overview
• Table 108 Ardelyx Company Overview
• Table 109 Ardelyx Financial Overview
• Table 110 Adocia Company Overview
• Table 111 Adocia Financial Overview
• Table 112 Aralez Pharmaceuticals Company Overview
• Table 113 Aralez Pharmaceuticals Financial Overview
• Table 114 Pivot Pharmaceuticals Company Overview
• Table 115 Pivot Pharmaceuticals Financial Overview
• Table 116 Other Prominent Players Company Overview
• Table 117 Other Prominent Players Financial Overview

관련자료